Author:
Zhang Huilai,Dong Ling,Chen Qingqing,Kong Lingzhe,Meng Bin,Wang Huaqing,Fu Kai,Wang Xi,Pan-Hammarström Qiang,Wang Ping,Wang Xianhuo
Funder
Natural Science Foundation of China
National Major Scientific and Technological Special Project
Scientific Research Foundation for the Returned Overseas Chinese Scholars in Tianjin
Natural Science Foundation of Tianjin Medical University
Subject
Cancer Research,Oncology,Hematology
Reference23 articles.
1. Distribution of lymphoid neoplasms in China: analysis of 4,638 cases according to the World Health Organization classification;Sun;Am. J. Clin. Pathol.,2012
2. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes;Vose;J. Clin. Oncol.,2008
3. The aggressive peripheral T-cell lymphomas: 2012 update on diagnosis, risk stratification, and management;Armitage;Am. J. Hematol.,2012
4. Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study;O'connor;J. Clin. Oncol.,2011
5. Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy;Coiffier;J. Clin. Oncol.,2012
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献